Unlike some of the managers I reviewed yesterday, Bruce Berkowitz and his cohorts at the Fairholme Capital have been buying. A scan of their Q3 2009 holdings spreadsheet suggests they favor healthcare companies and Berkshire Hathaway (BRK-A, BRK-B). Fairholme opened two new positions, both in the healthcare industry: Wyeth (WYE) and Cardinal Health (CAH). However, [...]
The Fairholme Fund have bounced back nicely in 2009, showing a 30% gain for the year. Quick summary follows but you can view Berkowitz’s portfolio moves in this spreadsheet. Their new positions seem to indicate that Berkowitz has changed his mind regarding some lukewarm comments about Berkshire Hathaway’s low growth potential a while back. He [...]
Of course, Warren Buffett is the most admired living investor but for my money, I appreciate Seth Klarman’s insights and approach as much if not more than the Oracle. Readers can see all of the Baupost Group’s portfolio moves in easy-to-read spreadsheet format here but below is a summary of items that caught my eye: [...]
Seth Klarman is one of the more secretive money managers out there so I don’t know what returns Baupost has generated in 2008. Here are some recent stories with his thoughts on current market conditions. Looking at his SEC filing, I see a few interesting moves: Klarman didn’t open any bold new positions other than [...]
Fairholme Capital, led by Bruce Berkowitz, runs a pretty focused portfolio and I found their most recent filing very interesting: Berkowitz’s two largest new positions were big stakes in Boeing (BA) and Northrop Grumman (NOC), the win-win US tanker contract trade, if you will. I have both on my watchlist and keep in mind that [...]
In their 13F-HR filing for Q2 2008, Bruce Berkowitz and his cohorts at the Fairholme Fund continue their shift from energy into healthcare:
